Relation of EPA and DHA content in cellular membranes of red blood cells to clinical outcome in patients hospitalized with chest pain.
- Prosjektnummer
- 911199
- Ansvarlig person
- Dennis W.T. Nilsen
- Institusjon
- Helse Stavanger HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Cardiac & Cardiovascular Systems
- Forskningsaktivitet
- Klinisk forskning
The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction.
Thromb Res 2007;119(4):415-21. Epub 2006 mai 2
PMID: 16650886
Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction.
Eur J Clin Nutr 2007 Mar. Epub 2007 mar 7
PMID: 17342163
Changes of plasma activated Factor XII type A (XIIaA) concentrations following percutaneous coronary intervention (PCI).
J Thromb Thrombolysis 2007 Oct;24(2):131-5. Epub 2007 mai 11
PMID: 17492403
Change to a primary PCI program increases number of patients offered reperfusion therapy and significantly reduces mortality: a real life experience evaluating the initiation of a primary PCI service at a single center without on site heart surgery in Western Norway.
Int J Cardiol 2008 Jul;127(2):208-13. Epub 2007 sep 4
PMID: 17765338
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
J Intern Med 2007 Aug;262(2):244-53.
PMID: 17645592
Late complications following the deployment of drug eluting stents.
Int J Cardiol 2006 May;109(3):398-401. Epub 2005 aug 18
PMID: 16102858
Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction.
Thromb Haemost 2006 Feb;95(2):329-36.
PMID: 16493496
Acute occlusion of the left subclavian artery causing a non-ST-elevation myocardial infarction with subacute lung edema due to a coronary subclavian steal syndrome--a case report.
Int J Cardiol 2006 Mar;108(1):139-41.
PMID: 16516713
Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients.
Am Heart J 2006 Nov;152(5):888-95.
PMID: 17070152
Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase.
J Thromb Thrombolysis 2006 Dec;22(3):199-203.
PMID: 17111198
Cardiac omega-3 content and risk of future cardiovascular events following an acute coronary syndrome.
European Heart Journal 2007;Vol.28 (Abstract Supplement):265: P3561, ESC Congress, Vienna 1-5 Sept 2007.
WENBIT - Western Norway B-vitamin intervention trial.
Hotline III, Session number 3220, presentation by Marta Ebbing on Sept. 4, ESC Congress, Vienna 1-5 Sept 2007.
The prognostic value of NT-proBNP versus PAPP-A, MPO and CD40L following a myocardial infarction.
European Heart Journal 2007;Vol.28 (Abstract Supplement):265: Oral presentation, abstract 1699. , ESC Congress 2007, Vienna1-5 Sept 2007.
Activated Factor XII Type A predicts cardiovascular outcome in patients admitted with chest pain.
European Heart Journal 2007;Vol.28 (Abstract Supplement):113: Poster presentation, ESC Congress 2007, Vienna 1-5 Sept. 2007.
Activated factor XII type A independently predicts 12 month mortality in chest pain patients.
Poster presentation at International Congress on Thrombosis and Haemostasis, Geneva, July 6-12, 2007. J Thromb Haemost 2007; Abstract ISTH 07A1_P-W-009.
NT-proBNP, and not TF, FM; PAPPA-A or CD40 Ligand, predicts recurrent troponin-T positive cardiac events following an acute myoc
Poster presentation at International Congress on Thrombosis and Haemostasis, Geneva, July 6-12, 2007. J Thromb Haemost 2007; Abstract ISTH 07A1_P-M-585.
WENBIT – Western Norway B-vitamin Intervention. 6th Conference on Homocysteine Metabolism.
World Congress on Hyperhomocysteinemia. Saarbruecken, Germany, June 5-9, 2007, Abstract P96.
Activated factor XII type A is an independent predictor of all-cause mortality in patients admitted with chest pain.
Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference Chicago, Illinois, April 19-21, 2007. Arterioscl Thromb Vasc Biol 2007; 27; e35-e137: e128, P519. Print ISSN: 1079-5642. Online ISSN: 1524-4636.
Changes in activated factor XII type A from admission to Day 4 predict recurrent troponin T positive cardiac events following ad
Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference Chicago, Illinois, April 19-21, 2007. Arterioscl Thromb Vasc Biol 2007; 27; e35-e137: e80, P243. Print ISSN: 1079-5642. Online ISSN: 1524-4636.
Omega-3 Index: A risk factor for ventricular fibrillation in the early post-myocardial infarction phase.
47th Annual Conference Cardiovascular disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism, Orlando, Florida. Circulation 2007; 115; e214-e301: e-237, Abstract P69. Print ISSN: 0009-7322. Onli
No effect of omega-3 versus corn oil intervention on Pregnancy-Associated Plasma Protein A (PAPP-A) and CD-40 Ligand following a
Circulation 2006; 113: e301-e381, abstrakt nummer P315.
No prognostic value of holo-transcobalamin or methylmalonic acid following an acute myocardial infarction.
Circulation 2006; 113: e301-e381, abstrakt nummer P325.
No Protection of a High Omega-3 Index Following an Acute Myocardial Infarction.
Atherosclerosis 2006; 7 (3): Suppl. pp 449.
No protection against new cardiac events of a high Omega-3 Index in patients presenting with an acute coronary syndrome.
Circulation 2006:114(18) (Suppl II): abstr 4176.
Activated Factor XII Type A Strongly Predicts All Cause Mortality after Hospitalisation with Chest Pain.
AACC Annual Meeting, 2006, Chicago, Abstract nr. D52.
Changes In Activated Factor XII From Admission To Day 4 Strongly Predict Recurrent Troponin-T Positive Cardiac Events At 30 Days
Pathophysiol Haemos Thromb2006; 35:199-248
] Activated Factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest pain
Eur Heart J 2006, 27(Abstract Suppl), 878
B-Type Natriuretic peptide is a predictor of all cause mortality at long-term follow-up after hospitalization with acute chest
Eur Heart J 2006, 27(Abstract Suppl), 570
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest